NDC 68084-348-11 - Losartan Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-348
- Requested NDC
- 68084-348-11
- Package NDCs from labels
- 68084-348-11, 68084-348-01
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-08-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Losartan Potassium - American Health Packaging | American Health Packaging | 2026-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-348-01 | Losartan Potassium | 100 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 100 | 9 | |
| 68084-348-11 | Losartan Potassium | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-348-01 | EA - Each | 68084-348 | 8e0fb305-225b-40ed-89a5-c873d66dc218 | 1 | 2012-07-24 |
| 68084-348-11 | EA - Each | 68084-348 | 946d3019-014d-47fe-9cd8-8efe27a9b767 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.